Citigroup Maintains Buy Rating for Cyxtera Technologies: Here's What You Need To Know
Citigroup has decided to maintain its Buy rating of Cyxtera Technologies (NASDAQ:CYXT) and lower its price target from $13.00 to $2.75.
Shares of Cyxtera Technologies are trading up 7.91% over the last 24 hours, at $2.12 per share.
A move to $2.75 would account for a 30.02% increase from the current share price.
About Cyxtera Technologies
Cyxtera Technologies Inc is engaged in data center colocation and interconnection services. The company operates a footprint of more than 60 data centers around the world, providing services to more than 2,300 leading enterprises and U.S. federal government agencies. Cyxtera brings proven operational excellence, global scale, flexibility and customer-focused innovation together to provide a comprehensive portfolio of data center and interconnection services.
About Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Must Read: 'Canadian Warren Buffett' Owns These Dividend Stocks: How To Invest Like The Billionaire
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Latest Ratings for CYXT
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | UBS | Initiates Coverage On | Neutral | |
Dec 2021 | RBC Capital | Initiates Coverage On | Outperform | |
Dec 2021 | Truist Securities | Initiates Coverage On | Buy |
View More Analyst Ratings for CYXT
View the Latest Analyst Ratings
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.